What is Vycor Medical Operating Cash Flow per Share?
Vycor Medical's operating cash flow per share for the
three
months ended in Mar. 2024 was $0.00.
Vycor Medical's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Vycor Medical's Operating Cash Flow per Share or its related term are showing as below:
During the past 13 years, Vycor Medical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 85.80% per year. The lowest was -125.40% per year. And the median was 40.90% per year.
Vycor Medical Operating Cash Flow per Share Historical Data
The historical data trend for Vycor Medical's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical Operating Cash Flow per Share Chart
|
Vycor Medical Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Operating Cash Flow per Share |
|
Get a 7-Day Free Trial
|
|
|
- |
-0.01 |
- |
-0.01 |
- |
|
Vycor Medical Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Operating Cash Flow per Share |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Vycor Medical's Operating Cash Flow per Share
For the Medical Devices subindustry, Vycor Medical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vycor Medical's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Vycor Medical's Price-to-Operating-Cash-Flow falls into.
Vycor Medical Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Vycor Medical's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Vycor Medical's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical (Vycor Medical) Business Description
Traded in Other Exchanges
N/A
Address
951 Broken Sound Boulevard, Suite 320, Boca Raton, FL, USA, 33487
Vycor Medical Inc is engaged in designing, developing and marketing medical devices for use in neurosurgery in the United States. It has developed ViewSite Brain Access System, which helps to reduce brain tissue trauma that arises from excessive pressure at the edges of the blade. It also provides non-invasive rehabilitation therapies for patients having disorders resulting from neurological brain damage caused by a stroke. The company operates through two segments: Vycor Medical, which focuses on devices for neurosurgery; and NovaVision, which focuses on neurostimulation therapies and diagnostic devices for the treatment and screening of visual field loss. The majority of the revenue comes from the Vycor Medical segment in the United States.
Executives
| David Cantor |
director, officer: President |
1 PORTMAN HOUSE HUE STREET, ST HELIER, JERSEY CHANNEL ISLANDS X0 00000 |
| Adrian Liddell |
director, officer: Chairman |
ROSEMOUNT, LYNCOMBE VALE ROAD, BATH HI BA2 4LP |
| Peter C Zachariou |
director, 10 percent owner, officer: Chief Executive Officer |
C/O QUE MANAGEMENT INC, 180 VENICK 13RH FL, NEW YORK NY 10014 |
| Lowell Rush |
director |
C/O DIRECT INSITE CORP., 500 EAST BROWARD BOULEVARD, SUITE 1550, FORT LAUDERDALE FL 33394 |
| Oscar Bronsther |
director |
4 AUTUMNWOOD COURT, THE WOODLANDS TX 77380 |
| Steven Girgenti |
director |
C/O HEALTHWORLD CORP, 100 AVENUE OF THE AMERICAS, NEW YORK NY 10013 |
| Fountainhead Capital Management Ltd |
10 percent owner |
PORTMAN HOUSE HUE STREET, ST HELIER, JERSEY CHANNEL ISLANDS X0 JE45RP |
Vycor Medical (Vycor Medical) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VYCO has been successfully added to your